社区实践中十年经颈动脉血运重建术的结局与见解
该研究回顾性分析了2013至2024年间在社区多中心私人诊所完成的655例经颈动脉血运重建术(TCAR),涉及588例患者。主要终点为30天卒中和心肌梗死发生率,结果分别为1.68%和0.15%。作者认为TCAR已成为治疗颈动脉狭窄的有效一线疗法,手术时间常少于1小时,结局与颈动脉内膜切除术相当或更优。
要点
- 30天心肌梗死发生率为0.15%(1例),1年内为0.91%(6例)。
- 颅神经损伤发生率为1.52%(10例),颈部血肿需清除发生率为1.53%(10例)。
核心结论
- TCAR已成为治疗合适颈动脉狭窄患者的有效且高效的一线疗法,手术时间常少于1小时。
- 早期采用该技术并整合入实践取得了优异的患者结局,与文献报道的颈动脉内膜切除术金标准相当或更优。
研究设计与样本
- 回顾性病历审查,纳入2013至2024年间在社区多中心私人诊所进行的655例TCAR手术,涉及588例患者。
- 队列包括10家医院的9名血管外科医生,所有手术均使用enroute经颈动脉神经保护系统。
主要发现
- 手术时403例患者(61.52%)为无症状,患者中位年龄为73岁(四分位距67-79岁)。
- 30天内发生心肌梗死1例(0.15%),1年内发生6例(0.91%)。
- 颅神经损伤10例(1.52%),其中吞咽困难1例、声音嘶哑9例;颈部血肿需清除10例(1.53%);动脉夹层1例(0.15%)。
临床怎么用
- 在社区实践中,TCAR可作为合适颈动脉狭窄患者的一线治疗选择,手术时间常少于1小时。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Transcarotid arterial revascularization (TCAR) with flow reversal is a well-established minimally invasive alternative to carotid endarterectomy. Our multicenter, private practice is an early adopter and has performed TCARs in the community since 2013. We report our real-world experience after performing 650 TCARs over 10 years in the community. METHODS: We performed 655 TCAR procedures on 588 patients between 2013 and 2024. A retrospective chart review was performed on these procedures. The cohort included 9 vascular surgeons across 10 hospitals. All procedures used the enroute transcarotid neuroprotection system, which uses common carotid access and high-rate flow reversal as embolic protection during stenting. The primary end points for this study are 30-day rates of stroke and myocardial infarction. Secondary end points included operative time, cranial nerve injury, neck hematoma requiring evacuation, arterial dissection, and death. RESULTS: We performed 655 TCAR procedures on 588 unique patients. At the time of surgery, 403 patients (61.52%) were asymptomatic. The median patient age was 73 years (interquartile range, 67-79 years). Patient medical history, surgical history, predilation and postdilation balloon sizes, stent sizes, operative time, flow reversal time, contrast volume, reoperation status, discharge statin, and anticoagulation therapies are listed and summarized in the tables. Eleven patients suffered a perioperative stroke (1.68%) within 30 days of the operations, and 10 (1.53%) suffered a stroke after 30 days but within 1 year of the operation. Myocardial infarction occurred in one patient (0.15%) within 30 days and six (0.91%) within 1 year. Cranial nerve injury occurred in 10 (1.52%) patients, defined as either dysphagia (n = 1) or hoarseness (n = 9). Neck hematoma with evacuation occurred in 10 patients (1.53%). An arterial dissection transpired in a single patient (0.15%). CONCLUSIONS: Over the last decade, TCAR has emerged as an effective and efficient first-line therapy for treating suitable patients with carotid artery stenosis regularly in less than 1 hour of operative time. Early adoption and integration of this technology into practice have yielded excellent patient outcomes, matching or surpassing those reported in the literature for the gold standard, carotid endarterectomy.
引用
- Kenny M, Landavazo B, Vernon C, et al. Outcomes and insights from a decade of transcarotid artery revascularization in community practice. J Vasc Surg. 2025. PMID: 40348294. doi:10.1016/j.jvs.2025.04.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。